G6PD deficiency (Glucose-6-Phosphate Dehydrogenase Deficiency)

What is G6PD deficiency?

G-6-PD deficiency is a hereditary, sex-linked enzyme defect that results in the breakdown of red blood cells when the person is exposed to the stress of infection or certain drugs.

Statistics on G6PD deficiency?

G-6-PD deficiency affects 400 million people worldwide. The highest prevalence rates (with gene frequencies from 5-25%) are found in tropical Africa, the Middle East, tropical and subtropical Asia, some areas of the Mediterranean, and Papua New Guinea.

Risk Factors for G6PD deficiency

Risk factors are being of African American descent, being male, or having a family history of G6PD deficiency. Another type of this disorder can occur in whites of Mediterranean descent. This form is also associated with acute episodes of hemolysis. Episodes are longer and more severe than in the other types of the disorder.

Progression of G6PD deficiency

Spontaneous recovery from this condition is the usual outcome.

How is G6PD deficiency Diagnosed?

  • Low red blood cell count and hemoglobin
  • Elevated bilirubin levels
  • Elevated serum LDH
  • Low serum haptoglobin

    Prognosis of G6PD deficiency

    Most individuals with G-6-PD deficiency do not need treatment.

    How is G6PD deficiency Treated?

    If the cause is an infection, it should be treated. If the cause is a drug, the offending agent should be stopped. People with the Mediterranean form, or those in hemolytic crisis may occasionally require transfusions.

    G6PD deficiency References

    [1] Beutler E: G6PD deficiency. Blood 1994 Dec 1; 84(11): 3613-36[Medline]. [2] Beutler E: Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 1991 Jan 17; 324(3): 169-74[Medline]. [3] Beutler E, Westwood B, Prchal JT: New glucose-6-phosphate dehydrogenase mutations from various ethnic groups. Blood 1992 Jul 1; 80(1): 255-6[Medline]. [4] eMEDICINE[5] MEDLINE Plus[6] Valaes T, Drummond GS, Kappas A: Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase- deficient newborns using an inhibitor of bilirubin production, Sn- mesoporphyrin. Pediatrics 1998 May; 101(5): E1[Medline].

    Article Tools:


    E-mail E-mail Bookmark/Add to Favourites Print Print twitter Twitter facebook Facebook

    Article Dates:

    calendar icon Created: 19/2/2004 calendar icon Modified: 7/2/2008
  • Current Sponsors
    Proudly brought to you by
    Proudly brought to you by
    Sponsors Logos
    Accreditation and Awards
    Accreditations and Awards
    Our site has been approved by the HealthInsite Editorial Board to be a HealthInsite information partner site PANDORA is a digital archive dedicated to the preservation of and long term access to Australian online electronic publications of national significance No. 1 Website in the Hitwise Top 10 Website Award in recognition of outstanding performance WAITTA Winner 2008 Online 2005 Finalist in the Secrets of Australian IT Innovation Awards Australian Prime Minister's awards for excellence in community business partnerships 2004
    2004 Finalist in the Secrets of Australian IT Innovation Awards
    Current Sponsors

    Virtual Medical Centre

    Please be aware that we do not give advice on your individual medical condition,
    if you want advice please see your treating physician.

    Information on this site must be discussed with your treating doctor.

    Virtual Medical Centre © 2002 - 2010 | Privacy Policy Last updated 30 Jul 2010

    For Banner Advertising
    MediaSmart

    Website and videos by
    Titan Interactive, Website and Web Design Perth Australia

    ^ Back to Top